Bayer stock trades at €48.29 as analysts keep a close watch

Bayer AG stock (ISIN DE000BAY0017) traded at €48.29 on August 20, 2026, while the current-year revenue view stands at €45.72 billion and next-year revenue at €46.94 billion. That setup leaves investors with a clear comparison: the market is pricing in a share at €48.29 as consensus still points to only modest top-line growth of €1.22 billion.

Consensus sets the frame

At 10:46:33 on August 20, 2026, the Bayer consensus snapshot showed the shares down 1.71 percent on the day and up 2.33 percent for 2026. The same table listed a median analyst target level of 48.29, which matches the quote and keeps valuation pressure in view as the year progresses.

The earnings side is equally specific. Analyst data in the same market snapshot points to current-year EPS of 4.46 and next-year EPS of 4.73, a gain of 0.27 per share that signals gradual improvement rather than a sharp step change.

What the numbers imply

Forecast revision data tied to the same Bayer dataset shows a current-quarter revenue expectation of €13.4 billion and a current-quarter earnings expectation of €2.76 billion for Q1 2026. It also shows a 39.32 percent decline versus the prior comparable quarter, followed by a 14.00 percent decline for the next quarter, which is the kind of trajectory that keeps investors focused on execution.

For the full year, the same snapshot implies a 9.10 percent decline, followed by 5.90 percent growth next year. That contrast matters more than any broad optimism story because it gives a concrete bridge between a weaker current year and a better-looking 2027 model.

Pharma and crop science

Bayer's business still rests on pharmaceuticals, consumer health, and crop science, and that mix shapes how the market reads its earnings power. The group's farm-input exposure adds cyclicality, while its prescription-drug franchise keeps the revenue base anchored to healthcare demand and patent cycles.

That combination is why the share price often reacts not just to current results but to the path from one reporting period to the next. In Bayer's case, the gap between €45.72 billion and €46.94 billion in revenue is small, so margin delivery and cash conversion carry extra weight.

Stock level and venue

Bayer stock trades on Xetra in euros, with the latest visible level at €48.29 on August 20, 2026. The share count, index membership, and the next earnings date can be added from verified company data when available.

Company details

Company: Bayer AG
ISIN: DE000BAY0017
Ticker: BAYN
Exchange: Xetra (Frankfurt)
Sector / Industry: Pharmaceuticals, crop science, and consumer health